<SEC-DOCUMENT>0001144204-15-053450.txt : 20150902
<SEC-HEADER>0001144204-15-053450.hdr.sgml : 20150902
<ACCEPTANCE-DATETIME>20150902164242
ACCESSION NUMBER:		0001144204-15-053450
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150827
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150902
DATE AS OF CHANGE:		20150902

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		151089946

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v419701_8-k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section&nbsp;13 or 15(d) of
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of Earliest Event Reported):
August 27, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><U>STAAR Surgical
Company</U></FONT><BR>
<FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 0; padding-left: 0; text-align: center; padding-top: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Delaware</U></FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="width: 32%; padding-right: 0; padding-left: 0; text-align: center; padding-top: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>0-11634</U></FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</FONT></TD>
    <TD STYLE="width: 34%; padding-right: 0; padding-left: 0; text-align: center; padding-top: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>95-3797439</U></FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center; padding-top: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center; padding-top: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; padding-top: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center; padding-top: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>1911
    Walker Ave, Monrovia, California</U> </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center; padding-top: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center; padding-top: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>91016</U></FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Not Applicable<BR>
</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 45%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Former name or former address, if changed since last report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 5.02</B></FONT></TD>
    <TD STYLE="width: 90%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective September 2, 2015, the Board of
Directors of STAAR Surgical Company (the &ldquo;Company&rdquo;) elected William P. Wall, 53, to serve as a member of the Board
of Directors. The Board approved providing Mr. Wall with the standard director compensation for a director, pro-rated for the remaining
portion of the 2015-2016 term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From February 2006 through June 2015, Mr.
Wall  served as General Counsel at Abrams Capital, an investment fund. Mr. Wall is currently a member of the Board of Directors,
and chair of the Corporate Governance Committee and member of the Audit Committee, of Haynes International, Inc., a publicly traded manufacturing
company, and has served as a Director there since 2004.
From June 2003 through April 2005, Mr. Wall served as a founding partner at Andover Capital, an investment fund. From 1996 through
2003, Mr. Wall worked for Fidelity Investments, initially as an Assistant General Counsel, then Vice President and Director of
Special Situations before founding and managing a private equity group focused on acquiring middle market companies for the firm&rsquo;s
own account. Mr. Wall began his career as an Associate at the law firm of Ropes &amp; Gray. He was a Trustee for the Boston Renaissance
Charter School for nine years and has worked as a Teaching Fellow at Harvard University. Previously, Mr. Wall served as a Director
of Automobile Holdings, Nations Commercial Finance and Eightfold Capital Management. Mr. Wall received his Bachelor of Arts from
the University of Massachusetts at Amherst, and a Masters of Public Administration and Juris Doctorate from Harvard University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The appointment of Mr. Wall to the Board
was not the result of any arrangement or understanding between him and any other person or entity. There are no transactions between
Mr. Wall nor any member of his immediate family and the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On August 27, 2015, Mr. Charles Slacik submitted
his resignation as a Director of the Company, to be effective August 31, 2015. Mr. Slacik&rsquo;s resignation was not submitted
as the result of any disagreement with the Company on any matter relating to the Company&rsquo;s operations, policies, or practices.
Mr. Wall will replace Mr. Slacik as a member of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 7.01</B></FONT></TD>
    <TD STYLE="width: 90%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Regulation FD Disclosure</B>.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 2, 2015, the Company published
a press release regarding the election of Mr. Wall to the Board. A copy of the press release is furnished as Exhibit 99.1 to this
report and is incorporated herein by this reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information furnished herewith pursuant
to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be &ldquo;filed&rdquo; for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities
of that section. The information in Item 7.01 of this Current Report shall not be incorporated by reference into any filing under
the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless
of any general incorporation language in the filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 9.01</B></FONT></TD>
    <TD STYLE="width: 90%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Financial Statements and Exhibits</B></FONT>.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Exhibit No.</U></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 87%; text-decoration: underline"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Description</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Press release of the Company dated September 2, 2015.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0; padding-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">September 2, 2015</FONT></TD>
    <TD STYLE="width: 3%">By:</TD>
    <TD STYLE="width: 47%; padding-right: 0; padding-left: 0; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> /s/ Caren Mason</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Caren Mason</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">President and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v419701_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 48.75pt; width: 117pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>William P. Wall Appointed to STAAR Surgical
Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MONROVIA, CA, September 2, 2015</B>--STAAR Surgical Company
(NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced
that its Board of Directors has appointed William P. Wall to the Company&rsquo;s Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Wall was formerly the General Counsel of Abrams Capital,
a Boston-based investment firm, for more than nine years. Mr. Wall is currently a member of the Board of Directors, and chair of
the Corporate Governance Committee and member of the Audit Committee, of Haynes International, Inc., a publicly traded manufacturing
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Bill Wall brings a significant legal, investment and
regulatory background that will support the company&rsquo;s efforts as STAAR works to execute on the growth opportunity for its
lenses. His expertise in compliance, knowledge of healthcare as the founding member of his own investment firm and work with a
number of manufacturing companies will add a valuable skillset and perspective to the Board. We look forward to his contributions,&rdquo;
said Mark Logan, Chairman of the Board of STAAR Surgical.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Wall was a founding partner of Andover Capital in 2003.
Prior to this, Mr. Wall worked for Fidelity Investments for seven years, initially as an Assistant General Counsel, then Vice President
and Director of Special Situations before founding and managing a private equity group focused on acquiring middle market companies
for the firm&rsquo;s own account. Mr. Wall began his career as an Associate at the law firm of Ropes &amp; Gray. He was a Trustee
for the Boston Renaissance Charter School for nine years and has worked as a Teaching Fellow at Harvard University. Previously,
Mr. Wall served as a Director of Automobile Holdings, Nations Commercial Finance and Eightfold Capital Management. Mr. Wall received
his Bachelor of Arts from the University of Massachusetts at Amherst, and a Masters of Public Administration and Juris Doctorate
from Harvard University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">STAAR also announced that Charles Slacik has retired from the
Board. Mr. Slacik joined the Board in September 2012. &ldquo;We are grateful to Charlie for his contributions to the Board and
service to STAAR&rsquo;s shareholders,&rdquo; said Mark Logan. &ldquo;We wish Charlie the very best in his future pursuits.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>About STAAR Surgical</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">STAAR, which has been dedicated solely to ophthalmic surgery
for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All
of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR&rsquo;s lens used in refractive
surgery as an alternative to LASIK is called an Implantable Collamer&reg; Lens or &ldquo;ICL.&rdquo; A lens used to replace the
natural lens after cataract surgery is called an intraocular lens or &ldquo;IOL.&rdquo; More than 500,000 Visian ICLs have been
implanted to date. To learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 employees and markets lenses
in over 60 countries. Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia,
CA. For more information, please visit the Company&rsquo;s website at www.staar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 15%; padding: 0"><font style="font: 10pt Times New Roman, Times, Serif">CONTACT:</font></td>
    <TD STYLE="width: 25%; padding: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Investors</b></font></td>
    <TD STYLE="width: 60%; padding: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Media</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</td>
    <TD STYLE="padding: 0"><font style="font: 10pt Times New Roman, Times, Serif">EVC Group</font></td>
    <TD STYLE="padding: 0"><font style="font: 10pt Times New Roman, Times, Serif">EVC Group</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</td>
    <TD STYLE="padding: 0"><font style="font: 10pt Times New Roman, Times, Serif">Brian Moore, 310-579-6199</font></td>
    <TD STYLE="padding: 0"><font style="font: 10pt Times New Roman, Times, Serif">Rob Swadosh, 212-850-6021</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</td>
    <TD STYLE="padding: 0"><font style="font: 10pt Times New Roman, Times, Serif">Doug Sherk, 415-652-9100</font></td>
    <TD STYLE="padding: 0">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "5 68# 2(  A$! Q$!_\0
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M6LZ=/:,>!(GSQG\?_P!=+G74?*SI**J6>J6&H+FTNXI?96Y'X=:MU1(4444
M%%%% !5=91_:,D.>?*5OU858K%CN@?&<UMGI9*?QWG_&DW8:-JBBBF(****
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M[:(3=O4JZ7I-II-OY5LGS-R\C<LY]2:O445JE8@**** "BBB@ HHHH ****
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M=8__ $*LOX-_\B_J'_7U_P"R"M3XI_\ (BW'_76/_P!"K+^#?_(OZA_U]?\
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MKGTFN9/$M]9OJ$T=O%"LB !/E)Z\E:&[ D=!16-X?U"YOA>I,XFC@G,<5P%
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MU<V.A2W5K.T4L97! !SE@.<CWK8C4I&JEV<@?>;&3^5%];#L.HHHIB"BBB@
MHHHH **** "BBB@ HHHH Q/%MM]I\-78QDQJ)![8.3^F:Q[R?/PRC/7,4:?D
MX']*ZZZA%Q:30'I(C(?Q&*X<JTWP_LK7D/)="'\?,-9SW?H7$ZKP];?9/#]C
M%C!\H,1[MR?YUITBJ$4*HP , 4M6E96(84444P"BBB@ HHHH BNFE2TF>!0T
MJH2BD=3C@5SFM6J:I:QSVUC<PZL"IC<1%2ASSN;H0!GO7444FKC3L(@8(H8Y
M;')]Z;-'YL$D><;U*Y^HI]%,1@:%-)INDQV%W:W*SP97Y(6=7&2000,?G6II
MT4D5LQE78\DCR%<_=W,2!]<8JW122L-L*Y>72TU+Q%J(N[67[-- D<<IC(PP
M[@]JZBBAJX)V,?19+ZW#Z=?PN6@^6*Y5?DE7MGT-;%%%"5A,PKVTN;3Q#'J]
MO$T\31>3/&GWP,Y# =^W%1ZY'_:\-I%;VDTDBW*.QDA9 JCKDL!^5=#12Y1W
M # P.E4]6#-I%VB([N\+HJHI))*D"KE%4Q&?H2O'HEG%)&\<D<2HRNI!! K0
M(!!!Z&BBDE9 <[HR3Z LVGW-O,]N)&>">*,N"I[$#D&MN"X:=B1#(D8'#2#:
M2?H>?SQ4]%"5M!MW"LN>.2^U94/GPPVR[E=5P'<\<$C' S_WU[5J44-7$<Z+
M:XTOQ.L\*W$]M=Q[;EMN=K#[K<#\/SKHJ**$K#;N8GBR":ZT":WMX9)99&7:
MJ*3T8$U;FU,I 3#9W4LN/E3R67)]R1@"M"BBVMPN S@9Z]Z***8@HHHH ***
M* "BBB@ HHHH **** "N5BMN;2TQA8]7D<#V 9Q_,5U594<'_$Y<D<"1Y1_W
M[1?ZFIDKC1JT4450@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ J/RP+@R=RN*** )**** "BBB@ HHHH **** "BBB@ HHHH ****
K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
